Abstract | BACKGROUND: It has been postulated that soybean isoflavones act as inhibitory factors in prostate cancer. However, to date there have been no case-controlled clinical studies carried out to compare the circulating concentrations of isoflavones in prostate cancer patients and control subjects. METHODS: RESULTS: The serum concentrations of isoflavones were compared in hospitalized and non-hospitalized subjects and for both the prostate cancer patients and the controls the concentrations were lower in the hospitalized subjects. The serum concentrations of genistein and daidzein were compared in subjects <70 years of age and subjects >/=70 years old and the levels were significantly lower in the younger group. Contrary to our expectation, comparison of the patient group and the control group revealed the serum concentrations of isoflavones to be higher in the patient group. Daidzein non-metabolizers were compared in the hospitalized experimental subjects of the patient group and the control group and they were significantly more common in the patient group. The poorly differentiated cancer patient group included a significantly lower percentage of daidzein metabolizers. CONCLUSIONS: The above findings revealed that equol itself or some unknown factor regulating the metabolism of daidzein is deeply involved in the biology of prostate cancer. Future studies are urgently needed to compare the incidence of daidzein metabolizers among various countries.
|
Authors | Hideyuki Akaza, Naoto Miyanaga, Naomi Takashima, Seiji Naito, Yoshihiko Hirao, Taiji Tsukamoto, Mitsuru Mori |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 32
Issue 8
Pg. 296-300
(Aug 2002)
ISSN: 0368-2811 [Print] England |
PMID | 12411567
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Isoflavones
- daidzein
- Genistein
- Prostate-Specific Antigen
|
Topics |
- Aged
- Case-Control Studies
- Genistein
(blood)
- Humans
- Isoflavones
(blood, metabolism)
- Male
- Prostate-Specific Antigen
(blood)
- Prostatic Neoplasms
(blood, diagnosis)
- Risk
- Soybeans
(chemistry)
|